BRCA2 and breast carcinoma: Moreover, a genetic analysis has identified a breast cancer‐related, BRCA2 single nucleotide polymorphism associated with plasma lipid levels and CVD (Asselbergs et al., 2012; Miao et al., 2017), as well as lipid and metabolite deregulation in individuals with BRCA2 mutations (Ramadan et al., 2015; Stanwell & Gluch, 2015).